Causes and pathogenesis of focal segmental glomerulosclerosis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Reviews Nephrology

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrneph.2014.216PMID 25447132PMCID PMC4772430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Focal Segmental Glomerulosclerosis.

  2017cited by this paper
• Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients

  2014cited by this paper
• The sclerosing glomerulus in mice and man: novel insights

  2014cited by this paper
• Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review

  2014cited by this paper
• Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.

  2014cited by this paper
• Basic Research: The long and the short of it—the temporal effects of renal lithium exposure are beginning to be unravelled

  2014cited by this paper
• The regenerative potential of parietal epithelial cells in adult mice.

  2014cited by this paper
• The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.

  2014cited by this paper
• Unraveling the role of podocyte turnover in glomerular aging and injury.

  2014cited by this paper
• The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.

  2014cited by this paper
• Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

  2014cited by this paper
• Smad2-Dependent Downregulation of miR-30 Is Required for TGF-β-Induced Apoptosis in Podocytes

  2013cited by this paper
• Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1

  2013cited by this paper
• mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking.

  2013cited by this paper
• Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease.

  2013cited by this paper
• Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease.

  2013cited by this paper
• APOL1 risk variants, race, and progression of chronic kidney disease.

  2013cited by this paper
• Rapamycin Upregulates Autophagy by Inhibiting the mTOR-ULK1 Pathway, Resulting in Reduced Podocyte Injury

  2013cited by this paper
• Proteinuria impairs podocyte regeneration by sequestering retinoic acid.

  2013cited by this paper
• Basic research: Podocyte progenitors and ectopic podocytes

  2013cited by this paper
• Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

  2013cited by this paper
• Has the circulating permeability factor in primary FSGS been found?

  2013cited by this paper
• Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis

  2013cited by this paper
• Low Birthweight and Premature Birth Are Risk Factors for Podocytopenia and Focal Segmental Glomerulosclerosis

  2013cited by this paper
• Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat.

  2013cited by this paper
• Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates

  2013cited by this paper
• Glomerular parietal epithelial cells in kidney physiology, pathology, and repair

  2013cited by this paper
• The treatment of minimal change disease in adults.

  2013cited by this paper
• Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.

  2013cited by this paper
• Association of histologic variants in FSGS clinical trial with presenting features and outcomes.

  2013cited by this paper
• Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.

  2013cited by this paper
• Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.

  2012cited by this paper
• Resolution of Recurrent Focal Segmental Glomerulosclerosis after Retransplantation

  2012cited by this paper
• De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.

  2012cited by this paper
• Podocyte Mitosis – A Catastrophe

  2012cited by this paper
• MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.

  2012cited by this paper
• Resolution of recurrent focal segmental glomerulosclerosis after retransplantation.

  2012cited by this paper
• Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis

  2012cited by this paper
• Emerging role of autophagy in kidney function, diseases and aging

  2012cited by this paper
• Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes

  2011cited by this paper
• What is a systematic review?

  2011cited by this paper
• Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.

  2011cited by this paper
• APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

  2011cited by this paper
• TGF-α Mediates Genetic Susceptibility to Chronic Kidney Disease

  2011cited by this paper
• TGF-alpha mediates genetic susceptibility to chronic kidney disease.

  2011cited by this paper
• Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection.

  2011cited by this paper
• US Renal Data System 2010 Annual Data Report.

  2011cited by this paper
• HIV-associated nephropathy: pathogenesis

  2011cited by this paper
• The targeted podocyte.

  2011cited by this paper
• Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

  2011cited by this paper
• Human nephron number: implications for health and disease

  2011cited by this paper
• Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

  2011cited by this paper
• Focal segmental glomerulosclerosis.

  2011cited by this paper
• Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis.

  2011cited by this paper
• Reversible cell cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling

  2011cited by this paper
• Podocyte injury damages other podocytes.

  2011cited by this paper
• Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).

  2010cited by this paper
• The Dutch Hunger Winter and the developmental origins of health and disease

  2010cited by this paper
• Development of focal segmental glomerulosclerosis after anabolic steroid abuse.

  2010cited by this paper
• Recurrence of focal segmental glomerulosclerosis in renal allograft: An in‐depth review

  2010cited by this paper
• Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

  2010cited by this paper
• Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

  2010cited by this paper
• Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

  2010cited by this paper
• Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.

  2010cited by this paper
• Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice.

  2010cited by this paper
• Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes

  2009cited by this paper
• PAI-1 and kidney fibrosis.

  2009cited by this paper
• Nephron number and individual glomerular volumes in male Caucasian and African American subjects.

  2009cited by this paper
• Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery

  2009cited by this paper
• Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies.

  2009cited by this paper
• Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis.

  2009cited by this paper
• Dystroglycan in the diagnosis of FSGS.

  2009cited by this paper
• CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).

  2009cited by this paper
• The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

  2008cited by this paper
• VEGF inhibition and renal thrombotic microangiopathy.

  2008cited by this paper
• Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism.

  2008cited by this paper
• VEGF inhibition and renal thrombotic microangiopathy.

  2008cited by this paper
• Fidelity and evolution of recurrent FSGS in renal allografts.

  2008cited by this paper
• The Notch pathway in podocytes plays a role in the development of glomerular disease

  2008cited by this paper
• Mechanisms of progression of chronic kidney disease

  2007cited by this paper
• Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome

  2007cited by this paper
• Effects of Podocyte Injury on Glomerular Development

  2007cited by this paper
• Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension.

  2006cited by this paper
• Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.

  2006cited by this paper
• The renin-angiotensin system in glomerular podocytes: Mediator of glomerulosclerosis and link to hypertensive nephropathy

  2006cited by this paper
• Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action.

  2006cited by this paper
• Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.

  2006cited by this paper
• Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.

  2006cited by this paper
• HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.

  2006cited by this paper
• TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.

  2005cited by this paper
• Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion.

  2005cited by this paper
• Proteomic patterns and prediction of glomerulosclerosis and its mechanisms.

  2005cited by this paper
• Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.

  2005cited by this paper
• Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.

  2005cited by this paper
• Interpreting segmental glomerular sclerosis

  2004cited by this paper
• The Emerging Role of

  2004cited by this paper
• Pathologic classification of focal segmental glomerulosclerosis: a working proposal.

  2004cited by this paper
• Cellular responses to protein overload: key event in renal disease progression

  2004cited by this paper
• Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP

  2004cited by this paper
• In Depth Review

  2003cited by this paper

• Single-cell transcriptomics and machine-learning reveal M1 macrophage-driven progression from minimal change disease to focal segmental glomerulosclerosis

  2026cites this paper
• Gene Modification: Exploring the potential in treating kidney diseases.

  2026cites this paper
• Melatonin in the pathogenesis and treatment of chronic kidney disease

  2026cites this paper
• Screening For Asymptomatic Renal Disease among School Children by Urinalysis

  2026cites this paper
• Ultrastructural and Immunohistochemical Alterations in Renal Tissue of Rats Exposed to Aflatoxin B1: Glomerular Barrier Disruption and Cytoskeletal Remodeling.

  2026cites this paper
• Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review

  2025cites this paper
• The Role of Dietary Polysaccharides in Uric Acid Regulation: Mechanisms and Benefits in Managing Hyperuricemia

  2025cites this paper
• Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders

  2025cites this paper
• Inflammation in glomerular diseases

  2025cites this paper
• Cell cycle disorders in podocytes: an emerging and increasingly recognized phenomenon

  2025cites this paper
• Efficacy of Rituximab as Adjunctive Therapy to Immunosuppressive Agents in Adult Primary Focal Segmental Glomerulosclerosis

  2025cites this paper
• Integration of metabolomics and transcriptomics reveals the mechanism of TMEM30A downregulation induced FSGS podocyte injury.

  2025cites this paper
• Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies

  2025cites this paper
• Systemic inflammation accelerates the development of focal segmental glomerulosclerosis in a mouse model of adriamycin induced nephrosis

  2025cites this paper
• Anti-mitochondrial antibody-positive inflammatory myopathy with multiple arrhythmias resistant to high-dose glucocorticoids and intravenous cyclophosphamide: a case-based review

  2025cites this paper
• Mettl3‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS

  2025cites this paper
• Non-linear histological alteration in the duodenum, Hepar, and renal mice following oral Aluminium exposure at varying doses

  2025cites this paper
• “ Advancing Nephrogenetics: Utilizing Single-Cell RNA Sequencing and Organoid Models for Precision Kidney Disease Treatment”

  2025cites this paper
• Role of Nuclear Scan in a Patient With Recurrent Focal Segmental Glomerulosclerosis Post-Transplantation: A Case Report.

  2025cites this paper
• Renal tubular acidosis: Varied aetiologies and clinical presentations: Three case reports

  2025cites this paper
• Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis: Circulating Factors, Molecular Biomarkers, and Treatments

  2025cites this paper
• Epidemiological profile and renal outcomes in a 25-year Brazilian cohort of glomerular diseases

  2025cites this paper
• Autosomal dominant focal segmental glomerulosclerosis by INF2 p.Arg218Trp and p.Ser186Pro mutations: three case reports and literature review

  2025cites this paper
• Focal Segmental Glomerulosclerosis: Comprehensive Review and Exploration of the Dual Potential of Cyclodextrins in Therapeutic Optimization

  2025cites this paper
• Clinicopathological and prognostic study of idiopathic membranous nephropathy with tip or non-tip variant focal segmental glomerulosclerosis: a single-center cohort study

  2025cites this paper
• Functional analysis of heterozygous variants in the SALL1 gene in 2 children with Townes-Brocks syndrome with FSGS

  2025cites this paper
• miRNAs involved in the TGFB signaling as possible markers of steroid-resistant nephrotic syndrome in children

  2025cites this paper
• A novel APOL1 membrane-addressing domain mutation (p.T272I) in Chinese twins with FSGS: implications for podocyte injury and ion channel disruption

  2025cites this paper
• Clinical implications of apolipoprotein L1 testing in patients with focal segmental glomerulosclerosis: a review of diagnostic and prognostic implications

  2025cites this paper
• Indications for genetic testing in adults with focal segmental glomerulosclerosis.

  2025cites this paper
• Kidney organoids: a 3-dimensional tool to unmask permeability factors in primary and recurrent FSGS.

  2025cites this paper
• Development of a Diagnostic Model for Focal Segmental Glomerulosclerosis: Integrating Machine Learning on Activated Pathways and Clinical Validation

  2025cites this paper
• Fertile Ground for Mathematical Modeling: Therapeutic and Diagnostic Nanoparticle Transport in the Glomerulus

  2025cites this paper
• Lived Experiences of Patients and Care Providers in Focal Segmental Glomerular Sclerosis and IgA Nephropathy

  2025cites this paper
• Deep Learning Enables Automated Segmentation and Quantification of Ultrastructure from Transmission Electron Microscopy Images

  2025cites this paper
• Glomerular disease registry and biobank: design and baseline results

  2025cites this paper
• Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis

  2025cites this paper
• Advances in focal segmental glomerulosclerosis research: genetic causes to non-coding RNAs

  2025cites this paper
• Case Report: Pneumomediastinum and pulmonary embolism in a 19-year-old with focal segmental glomerulosclerosis: a rare double-complication of corticosteroid therapy

  2025cites this paper
• Perfil epidemiológico e desfechos renais em uma coorte Brasileira de 25 anos de doenças glomerulares

  2025cites this paper
• Integrating Traditional Chinese Medicine in the Management of Podocytopathies

  2025cites this paper
• Marcadores inflamatorios y su correlación con alteración de la función renal, estancia hospitalaria y mortalidad en pacientes con infección severa por COVID-19. Un estudio observacional de centro único.

  2025cites this paper
• The nuclear export inhibitor selinexor improves kidney function in a rat model of focal segmental glomerulosclerosis.

  2025cites this paper
• The role of endothelin receptor antagonists in kidney disease

  2025cites this paper
• Electron Microscopy in Renal Biopsy Interpretation: When and Why It Still Matters

  2025cites this paper
• Report of the ASFA Apheresis Registry Study on Focal Segmental Glomerulosclerosis

  2025cites this paper
• Anti-Nephrin Antibodies in Adult Chinese Patients with Minimal Change Disease and Primary Focal Segmental Glomerulosclerosis.

  2025cites this paper
• Dual Acting Inhibitor of Soluble Epoxide Hydrolase and Cyclooxygenase-2, Attenuates Glomerular Injury in Renal Hypoplasia Mice.

  2025cites this paper
• Microarray analysis of the effects of Acthar Gel versus methylprednisolone in a model of focal segmental glomerulosclerosis in female rats

  2025cites this paper
• Dapatkah Progresivitas Penyakit Ginjal Kronik pada Anak Kita Hentikan?: Suatu Perspektif Proteomik pada Penyakit Glomerulus

  2025cites this paper
• Primary focal segmental glomerulosclerosis in second trimester pregnancy presenting as rapidly progressive renal failure: diagnostic and therapeutic challenges: a case report

  2025cites this paper
• Traditional, alternative, and emerging therapeutics for focal segmental glomerulosclerosis

  2025cites this paper
• Purinergic Receptor Activation Protects Glomerular Microvasculature from Increased Mechanical Stress in Angiotensin II-Induced Hypertension: A Modeling Study

  2025cites this paper
• Current and Future Therapeutics for Focal Segmental Glomerular Sclerosis in the Era of Precision Medicine: A Review.

  2025cites this paper
• Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury

  2025cites this paper
• Kidney immunology from pathophysiology to clinical translation

  2025cites this paper
• Nephroprotective Effects of Curcumin in Murine Models of Focal and Segmental Glomerulosclerosis

  2025cites this paper
• Potential biomarkers of recurrent FSGS: a review

  2024cites this paper
• Unveiling the podocyte-protective effect of sodium-glucose cotransporter-2 inhibitors

  2024cites this paper
• Aberrant frequency of circulating IL-21+ T follicular helper cells in patients with primary focal segmental glomerulosclerosis.

  2024cites this paper
• Rapamycin-associated nephropathy; a short look at the new findings

  2024cites this paper
• Immune landscape in the glomerular transcriptome of nephrotic syndrome and anca-associated vasculitis

  2024cites this paper
• Remaja perempuan dengan hipertensi sekunder dan chronic kidney disease (CKD) on hemodialisis akibat sindrom nefrotik: sebuah laporan kasus

  2024cites this paper
• Fenestrated Endothelial Cells across Organs: Insights into Kidney Function and Disease

  2024cites this paper
• Fibrosis uncovered: ADAMTS12 cuts to the core of extracellular matrix drama

  2024cites this paper
• Pathological and Etiological Aspects of Nephrotic Syndrome at the Niamey General Reference Hospital

  2024cites this paper
• CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes

  2024cites this paper
• Zinc Deficiency Causes Glomerulosclerosis and Renal Interstitial Fibrosis Through Oxidative Stress and Increased Lactate Metabolism in Rats

  2024cites this paper
• Syndromes et explorations en néphrologie

  2024cites this paper
• Modeling the interaction between tubuloglomerular feedback and myogenic mechanisms in the control of glomerular mechanics

  2024cites this paper
• The role of mitochondrial dysfunction in kidney injury and disease.

  2024cites this paper
• Human Adipose Tissue-Derived Stromal Cells Ameliorate Adriamycin-Induced Nephropathy by Promoting Angiogenesis

  2024cites this paper
• A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.

  2024cites this paper
• INF2 formin variants linked to human inherited kidney disease reprogram the transcriptome, causing mitotic chaos and cell death

  2024cites this paper
• Discovery of pyridazinone derivatives bearing tetrahydroimidazo[1,2-a]pyrazine scaffold as potent inhibitors of transient receptor potential canonical 5 to ameliorate hypertension-induced renal injury in rats.

  2024cites this paper
• Significance of genetic analysis in adult patients with inherited chronic kidney disease

  2024cites this paper
• Nephrotic Syndrome: A Review

  2024cites this paper
• Mice with a Pax2 missense variant display impaired glomerular repair.

  2024cites this paper
• Development and Characterization of a Novel FVB-PrkdcR2140C Mouse Model for Adriamycin-Induced Nephropathy

  2024cites this paper
• Heterogeneous Nuclear Ribonucleoprotein F Deficiency in Mouse Podocyte Promotes Podocytopathy Mediated by Methyltransferase-like 14 Nuclear Translocation Resulting in Sirtuin-1 Gene Inhibition.

  2024cites this paper
• Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft

  2024cites this paper
• Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort

  2024cites this paper
• Focal segmental glomerulosclerosis (FSGS) in pregnancy: The case of a 27-year-old woman with nephrotic syndrome at 22 weeks of gestation

  2024cites this paper
• MicroRNA193a: An Emerging Mediator of Glomerular Diseases

  2023cites this paper
• Ferroptosis is involved in focal segmental glomerulosclerosis in rats

  2023cites this paper
• AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome

  2023cites this paper
• Sparsentan - Another Arrow in the Quiver for Treatment of FSGS?

  2023cites this paper
• FSGS Recurrence Collaboration: Report of a Symposium

  2023cites this paper
• Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis

  2023cites this paper
• Expansion of Anticomplement Therapy Indications from Rare Genetic Disorders to Common Kidney Diseases.

  2023cites this paper
• Nephrotic Syndrome in Pediatrics: A Case Report

  2023cites this paper
• Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.

  2023cites this paper
• Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China

  2023cites this paper
• Evaluation of glomerular sirtuin-1 and claudin-1 in the pathophysiology of nondiabetic focal segmental glomerulosclerosis

  2023cites this paper
• Clinicopathological differences in focal segmental glomerulosclerosis depending on the accompanying pathophysiological conditions in renal allografts

  2023cites this paper
• Hippo signaling in acute kidney injury to chronic kidney disease transition: current understandings and future targets.

  2023cites this paper
• CD8 T Cell‐Derived Exosomal miR‐186‐5p Elicits Renal Inflammation via Activating Tubular TLR7/8 Signal Axis

  2023cites this paper
• Implementation and Feasibility of Clinical Genome Sequencing Embedded Into the Outpatient Nephrology Care for Patients With Proteinuric Kidney Disease

  2023cites this paper
• Fucoidan from Saccharina japonica Alleviates Hyperuricemia-Induced Renal Fibrosis through Inhibiting the JAK2/STAT3 Signaling Pathway.

  2023cites this paper
• Fibrosis in Pathology of Heart and Kidney: From Deep RNA-Sequencing to Novel Molecular Targets

  2023cites this paper